Výsledky vyhledávání - "E. Oppliger Leibundgut"

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Publikováno v: Leukemia; 29(5), pp 999-1003 (2015)
Leukemia
Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Polakova, K M, Dulucq, S, Martinelli, G, Leibundgut, E O, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Muller, M C & Hochhaus, A 2015, ' Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia ', Leukemia, vol. 29, no. 5, pp. 999-1003 . https://doi.org/10.1038/leu.2015.29
Cross, N C P; White, H E; Colomer, D; Ehrencrona, H; Foroni, L; Gottardi, E; Lange, T; Lion, T; Machova Polakova, K; Dulucq, S; Martinelli, G; Oppliger Leibundgut, Elisabeth; Pallisgaard, N; Barbany, G; Sacha, T; Talmaci, R; Izzo, B; Saglio, G; Pane, F; Müller, M C; ... (2015). Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia, 29(5), pp. 999-1003. Nature Publishing Group 10.1038/leu.2015.29

Treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors has advanced to a stage where many patients achieve very low or undetectable levels of disease. Remarkably, some of these patients remain in sustained remission when treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090442081ee84349b7dcc0f774bb673a
http://hdl.handle.net/11585/548720

Zobrazit plný text záznamu

Real-time process/quality control for HPC processing

Autor: K. Zbären, E Oppliger Leibundgut, M Arpagaus, A. Tobler, Claudio Brunold, E. Ischi, Caroline Zwicky

Publikováno v: Cytotherapy. 6:505-513

Background JACIE Standards (FACT Standards in the USA) have been implemented in Europe since 1999. An on-site accreditation inspection took place at our center in January 2004. The purpose of this work was to develop a real-time process/ quality cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df5a5d5d0d31f92c256019d68c2ac0b
https://doi.org/10.1080/14653240410005032

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Publikováno v: Jovanovic, J V, Ivey, A, Vannucchi, A M, Lippert, E, Oppliger Leibundgut, E, Cassinat, B, Pallisgaard, N, Maroc, N, Hermouet, S, Nickless, G, Guglielmelli, P, van der Reijden, B A, Jansen, J H, Alpermann, T, Schnittger, S, Bench, A, Tobal, K, Wilkins, B, Cuthill, K, McLornan, D, Yeoman, K, Akiki, S, Bryon, J, Jeffries, S, Jones, A, Percy, M J, Schwemmers, S, Gruender, A, Kelley, T W, Reading, S, Pancrazzi, A, McMullin, M F, Pahl, H L, Cross, N C P, Harrison, C N, Prchal, J T, Chomienne, C, Kiladjian, J J, Barbui, T & Grimwade, D 2013, ' Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN &MPNr-EuroNet (COST action BM0902) study ', Leukemia, vol. 27, no. 10, pp. 2032-2039 . https://doi.org/10.1038/leu.2013.219

Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has been no consistent approach to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105dd652470953e772a177d47b59293c
https://pure.qub.ac.uk/en/publications/d05beb10-960c-4cca-8370-7f03728ddc47

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání